Сообщения

Сообщения за Февраль, 2016

Novartis-Krebsmittel erhält weitere US-Zulassung für Afinitor

Novartis-Krebsmittel erhält weitere US-Zulassung für Afinitor
(dpa-AFX) Der Schweizer Pharmakonzern Novartis hat von der US-Gesundheitsbehörde FDA eine weitere Zulassung für das Krebsmedikament Afinitor erhalten. Dabei geht es um die Behandlung bestimmter fortgeschrittener Tumore, die sich aus der Lunge oder dem Verdauungstrakt heraus entwickelt haben, wie das...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Matterhorn Capital Management LLC Boosts Stake in Shire PLC

Matterhorn Capital Management LLC Boosts Stake in Shire PLC
Matterhorn Capital Management LLC boosted its position in Shire PLC by 0.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,168 shares of the biopharmaceutical company's stock after buying an additional 104 shares during the period.

from Biotech News

Esperion Therapeutics Inc (ESPR) to Post FY2015 Earnings of ($2.36)...

Esperion Therapeutics Inc (ESPR) to Post FY2015 Earnings of ($2.36)...
Esperion Therapeutics Inc - Lake Street Capital decreased their FY2015 earnings per share estimates for shares of Esperion Therapeutics in a research note issued to investors on Thursday, according to Zacks Investment Research . Lake Street Capital analyst C. Byrnes now forecasts that the brokerage will earn per share for the year, down from their prior forecast of .

from Biotech News

Pearson returns as Valeant CEO following illness

Pearson returns as Valeant CEO following illness
Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news. With a traditional newspaper format, more than 100 sites were established each with a newspaper-type name to cover the highest-ranked regions, countries, cities and states.

from Biotech News

Dividend Growth Stocks For Roth IRAs

Dividend Growth Stocks For Roth IRAs
The beauty of compounding dividends over time can be seriously slowed down by taxes. That is why placing dividend payers in a Roth IRA can be such an advantage.

from Biotech News

4 tools to protect yourself from assault

4 tools to protect yourself from assault
An oft-quoted 1998 study by the National Institute of Justice and Centers for Disease Control and Prevention found that one in every six women and one in 33 men in the United States has at one time or another been the victim of rape or attempted rape. An oft-quoted 1998 study by the National Institute of Justice and Centers for Disease Control and Prevention found that one in every six women and one in 33 men in the United States has at one time or another been the victim of rape or attempted rape.

from Biotech News

L.B. Bohle steigert Umsatz auf 48 Mio. €: Pharma-Industrie nutzt Technology Center

Изображение
L.B. Bohle steigert Umsatz auf 48 Mio. €: Pharma-Industrie nutzt Technology Center

Die Investitionen in die Zukunft haben sich für die L. B. Bohle Maschinen + Verfahren GmbH im Geschäftsjahr 2015 ausgezahlt: Der Spezialmaschinenbauer für die Pharma-Industrie hat seinen Umsatz um 26 Prozent auf 48 Mio. € gesteigert. „In den USA haben wir gegen starken Wettbewerb einen prestigeträch...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

First case of sexually transmitted Zika virus seen in France

First case of sexually transmitted Zika virus seen in France
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Feb. 26, 2015, the U.S. government said Zika infections have been confirmed in nine pregnant women in the United States.

from Biotech News

Janus Capital Management Has $27,663,000 Stake in Mylan NV

Janus Capital Management Has $27,663,000 Stake in Mylan NV
Janus Capital Management raised its stake in Mylan NV by 1,608.1% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 687,099 shares of the company's stock after buying an additional 646,874 shares during the period.

from Biotech News

Forty killed in Saudi-led airstrikes northeast of Yemen's Sanaa

Forty killed in Saudi-led airstrikes northeast of Yemen's Sanaa
Clinton looks to win big in S.C. But her win would have more of a symbolic value, as it would massively reduce any momentum that Bernie Sanders may have left. But he's focusing most of his attention on states in the Midwest and Northeast, including his home state of Vermont .

from Biotech News

Sinovac Biotech Ltd. (SVA) Sees Significant Decrease in Short Interest

Sinovac Biotech Ltd. (SVA) Sees Significant Decrease in Short Interest
Sinovac Biotech Ltd. was the recipient of a significant drop in short interest in the month of February. As of February 12th, there was short interest totalling 526,240 shares, a drop of 55.9% from the January 29th total of 1,194,312 shares, MarketBeat reports.

from Biotech News

Noble Financial Reaffirms "Buy" Rating for BioCryst Pharmaceuticals, Inc.

Noble Financial Reaffirms "Buy" Rating for BioCryst Pharmaceuticals, Inc.
's stock had its "buy" rating restated by Noble Financial in a research report issued to clients and investors on Friday, Analyst Ratings Network.com reports. They presently have a $8.00 target price on the biotechnology company's stock.

from Biotech News

SPDR S&P Biotech (Xbi) Shares Sold by Chevy Chase Trust Holdings

SPDR S&P Biotech (Xbi) Shares Sold by Chevy Chase Trust Holdings
Chevy Chase Trust Holdings lowered its stake in SPDR S&P Biotech by 12.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,538 shares of the company's stock after selling 3,329 shares during the period.

from Biotech News

MannKind Without Al Mann

MannKind Without Al Mann
MannKind investors received the terrible news that the founder of the company, Al Mann, passed away Thursday. The news was indeed a sad day.

from Biotech News

Novartis AG (NVS) Position Boosted by Eagle Asset Management

Novartis AG (NVS) Position Boosted by Eagle Asset Management
Eagle Asset Management increased its position in Novartis AG by 99.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 12,160 shares of the company's stock after buying an additional 6,073 shares during the period.

from Biotech News

Charles River Labs has become an indispensable player in biotech

Charles River Labs has become an indispensable player in biotech
Charles River Laboratories International Inc. might be the most important life sciences player you've never heard of. Founded in 1947, the contract research company is more than twice as old as the biotech industry it serves.

from Biotech News

Inventor Alfred E. Mann dies; helped develop pacemakers

Inventor Alfred E. Mann dies; helped develop pacemakers
Philanthropist Alfred E. Mann, an entrepreneur and inventor whose wide-ranging business endeavors included aerospace, pharmaceuticals, electronic circuitry and biomedical research, has died. He was 90. His death on Thursday was announced by MannKind Corp., where Mann served as chairman of the Valencia, California-based company from 2001 to earlier this month.

from Biotech News

CDC: Zika infections confirmed in 9 pregnant women in US

CDC: Zika infections confirmed in 9 pregnant women in US
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Feb. 26, 2015, the U.S. government said Zika infections have been confirmed in nine pregnant women in the United States.

from Biotech News

Best And Worst Q1'16: All Cap Growth ETFs, Mutual Funds And Key Holdings

Best And Worst Q1'16: All Cap Growth ETFs, Mutual Funds And Key Holdings
IUSG is our top-rated All Cap Growth ETF and JGISX is our top-rated All Cap Growth mutual fund. The All Cap Growth style ranks seventh out of the twelve fund styles as detailed in our Q1'16 Style Ratings for ETFs and Mutual Funds report.

from Biotech News

The Verdict Against Johnson & Johnson Doesn't Mean More Judgements Will Follow

The Verdict Against Johnson & Johnson Doesn't Mean More Judgements Will Follow
The $72 million verdict this week against Johnson & Johnson in a U.S. case alleging links between talc-based powder and ovarian cancer has prompted global headlines, social-media buzz and calls to lawyers from would-be plaintiffs. But the attention-grabbing judgment is no guarantee future plaintiffs will be able to convince juries the company's products caused their illnesses.

from Biotech News

Are you at risk for viral hepatitis? This quiz could help save your life

Are you at risk for viral hepatitis? This quiz could help save your life
If you answered "yes" to any of these questions, you could be at risk for viral hepatitis. The Centers for Disease Control and Prevention developed a five-minute quiz to help people find out if they should be tested or vaccinated for viral hepatitis.

from Biotech News

Officials: 18 sickened by packaged salads from Ohio plant

Officials: 18 sickened by packaged salads from Ohio plant
Health officials say more than a dozen people have become sickened by a listeriosis outbreak connected to a Dole processing plant in southwest Ohio. The Centers for Disease Control and Prevention reported Thursday that three more people have fallen ill, including two from Ohio and one from Missouri.

from Biotech News

FDA Addresses ASHP Concerns in Pre-Published Guidance

FDA Addresses ASHP Concerns in Pre-Published Guidance
The Food and Drug Administration (FDA) today announced the availability of a guidance for industry entitled “Requirements for Transactions with First Responders under Section 582 of the Federal Food, Drug, and Cosmetic Act — Compliance Policy.” The guidance specifically addresses concerns raised by ASHP and its members over the ability of hospitals to supply first responders with medications in anticipation of emergent use or specific patient need. On February 5 of this year, ASHP sent a letter to then-FDA Commissioner Stephen Ostroff, M.D., outlining these concerns and the need for further guidance on Drug Quality and Security Act (DQSA) requirements. DQSA was signed into law in 2013. Title II of DQSA creates a pharmaceutical tracking system to account for medications throughout the supply chain. Under this new framework, pharmacies (dispensers) must collect and store certain drug information for up to six years. Originally these …

Johnson & Johnson slammed with $72 MILLION verdict for...

Johnson & Johnson slammed with $72 MILLION verdict for...
A Missouri jury has ordered pharmaceutical and health giant Johnson & Johnson to pay $72 million in damages to the family of a woman who died of ovarian cancer after using the company's talc-based baby powder for decades. The jury found that J&J was aware of research linking talc to cancer , but deliberately chose to cover it up rather than warning consumers.

from Biotech News

Pharmacy Students Push for Provider Status on Capitol Hill

Pharmacy Students Push for Provider Status on Capitol Hill
Nearly 50 students visited 31 congressional offices on Capitol Hill earlier this month as part of ASHP’s Student Advocate Training & Legislative Day. The two-day conference, also known as SSHPTakesDC, gives student pharmacists hands-on experience in how to directly affect public policy. During meetings at the U.S. Capitol with members of Congress and legislative staff, the students made the case for provider status legislation, the Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592 and S.314), by emphasizing how the pharmacy school curriculum and postgraduate residency training prepare future practitioners to be patient care providers. “I feel like we had a good impact,” said Winston Johnson, a third-year student at Palm Beach Atlantic University in West Palm Beach, Fla. “We met with a health LA [legislative aide] who didn’t know much about pharmacy. We took the time to tell her all about our training and go…

Some experts contend Brazil is exaggerating Zika crisis

Some experts contend Brazil is exaggerating Zika crisis
Brazilian and U.S. health workers from the United States' Centers for Disease Control and Prevention talk with a resident Wednesday, Feb. 24, 2016, as they search for mothers and infants to recruit for a study aimed at determining whether the Zika virus is causing babies to be born with a birth defect affecting the brain in Joao Pessoa, Brazil. Their goal is to persuade about 100 mothers of infants recently born with the defect as well to enroll in the study.

from Biotech News

4 Biotech Stocks Recommended by Citigroup Analysts

4 Biotech Stocks Recommended by Citigroup Analysts
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 9+ You may proceed to the site by clicking here , however some pages might not work correctly.

from Biotech News

Bayer-Chef Dekkers verabschiedet sich mit Rekord

Bayer-Chef Dekkers verabschiedet sich mit Rekord
(dpa) Der künftige Bayer-Chef Werner Baumann kann die Früchte der erfolgreichen Pharmaforschung der vergangenen Jahre ernten. Die Umsätze des Traditionsunternehmens mit den fünf in den vergangenen Jahren neu auf den Markt gebrachten «Blockbuster»-Medikamenten - Xarelto, Eylea, Adempas, Stivarga und ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Tax group blasts Pfizer, urges stop to its tax-cutting deal

Tax group blasts Pfizer, urges stop to its tax-cutting deal
A consumer coalition is accusing drugmaker Pfizer of seeking to avoid $35 billion in U.S. taxes by buying fellow drugmaker Allergan, a deal structured to nominally move Pfizer's address to lower-tax Ireland, Allergan's home. In a report, Americans for Taxpayer Fairness says that would also slash New York-based Pfizer's future U.S. taxes.

from Biotech News

Stroke patients show higher recovery in MultiStem therapy studied at UH Case Med Center

Stroke patients show higher recovery in MultiStem therapy studied at UH Case Med Center
Data presented by the biotech company Athersys indicate that stroke patients treated by an adult stem cell therapy called MultiStem did significantly better than others who received a placebo one year after treatment. The results are from a Phase 2 study involving clinical sites in the United States and the United Kingdom, including University Hospitals Case Medical Center.

from Biotech News

Amazon Prime is popular with American households

Amazon Prime is popular with American households
CNN Money reported Amazon's trademarked brands are selling more than 1,700 items on the company's website and most are under $100. The company has only been selling clothing for a few months and only 15 percent of shoppers are buying clothing from Amazon but they are hoping this number grows as they introduce more lines and items.

from Biotech News

Ionis Could Spike Due To Breakthrough

Ionis Could Spike Due To Breakthrough
I believe that validation of Ionis's platform could make Ionis go up like Regeneron did after Regeneron's first big breakthrough. Ionis Pharmaceuticals is a $4.2 billion market cap company.

from Biotech News

Jury Awards Family $72M in Johnson & Johnson Talcum Powder Lawsuit

Jury Awards Family $72M in Johnson & Johnson Talcum Powder Lawsuit
A jury has awarded the family of a Missouri woman $72 million in a civil suit -- a court battle carried on by Marvin Salter on behalf of his late mother. On Monday, a St. Louis jury found Johnson & Johnson liable for Jackie Fox's ovarian cancer, which she claimed in the lawsuit was the result of using the company's Baby Powder and Shower to Shower powder, both of which contained talcum powder, according to court documents.

from Biotech News

3 pregnant women in Florida test positive for Zika virus

3 pregnant women in Florida test positive for Zika virus
This 2006 photograph depicted a female Aedes aegypti mosquito while she was in the process of acquiring a blood meal from her human host. The mosquito is a primary transmitter of the Zika virus.

from Biotech News

Retirement Investing: Buying Pfizer For A 4.7% Dividend

Retirement Investing: Buying Pfizer For A 4.7% Dividend
Today, the dividend yield is over 4%. However, starting in 2017, you can get the same dividend at a yield closer to 5% by buying Allergan today or by trading out existing Pfizer exposure into AGN.

from Biotech News

Wechsel an der Bayer-Spitze

Wechsel an der Bayer-Spitze
(dpa) Schneller Führungswechsel bei Bayer: Strategie-Chef Werner Baumann wird bereits zum 1. Mai die Nachfolge des scheidenden Konzernchefs Marijn Dekkers antreten. Der Vertrag von Dekkers werde vorzeitig aufgelöst, wie der Konzern am Mittwoch nach einer Aufsichtsratssitzung mitteilte. Für Bayer beg...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Indiana biosciences institute getting more than $100M

Indiana biosciences institute getting more than $100M
Indiana's fledgling biosciences institute is getting more than $100 million to help spur its collaborations between industry and academia. Officials announced Wednesday that the Lilly Endowment is making an $80 million grant to the Indiana Biosciences Research Institute and Eli Lilly and Co.

from Biotech News

4SC AG: FDA genehmigt IND-Antrag für Resminostat in Leberkrebs

4SC AG: FDA genehmigt IND-Antrag für Resminostat in Leberkrebs
Die 4SC AG hat von der US-amerikanischen Arzneimittelzulassungsbehörde FDA (Food and Drug Administration) eine IND-Genehmigung (Investigational New Drug) für die Durchführung einer klinischen Studie mit Resminostat in Kombination mit der Standardtherapie Sorafenib zur Erstlinienbehandlung von Patien...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Erin Andrews blames hotel for nude videos; Marco Rubio 0-4 and...

Erin Andrews blames hotel for nude videos; Marco Rubio 0-4 and...
Erin Andrews blamed the hotel where nude videos of her were recorded in her $75 million lawsuit. Donald Trump's triumph in Nevada increases doubts about Marco Rubio's strategy.

from Biotech News

Cancer research UK launches trial for potential new drug that could help immune system fight cancer

Cancer research UK launches trial for potential new drug that could help immune system fight cancer
Cancer Research UK's Centre for Drug Development , in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours. Cancer Research UK scientists are studying Amgen's experimental cancer drug, called AMG319, to find out if it removes the defence shield that hides cancer cells from the immune system.

from Biotech News

MannKind founder resigns

MannKind founder resigns
MannKind founder Al Mann will continue to have close ties with the company despite his resignation last week from the drug maker's board of directors, CEO Matt Pfeffer said Tuesday. "Al Mann's resignation has caused a lot of concern in some quarters," CEO Matt Pfeffer said on a webcast of the RBC Healthcare conference in New York City.

from Biotech News

Logistics cause delays on first day of Brazil Zika study

Logistics cause delays on first day of Brazil Zika study
"' U.S. and Brazilian health workers seeking to determine if the Zika virus is causing a surge in birth defects ran into the chaotic reality of northeastern Brazil on their study's first day Tuesday. Traffic and logistical problems shredded their schedule, delaying or preventing meetings with mothers and babies.

from Biotech News

CDC: 14 more US reports of possible Zika spread through sex

CDC: 14 more US reports of possible Zika spread through sex
This January 2016 microscope image provided by the Centers for Disease Control and Prevention shows the Zika virus.

from Biotech News

Judge: Police recordings not given to killer's lawyers

Judge: Police recordings not given to killer's lawyers
A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which she said was caused by using Johnson & Johnson's well-known baby powder and other products containing... Phoenix police and firefighters braved bullets and flames as they responded to a shooting and house fire that left four people dead Tuesday, including the gunman, authorities said. Phoenix police and firefighters braved bullets and flames as they responded to a shooting and house fire that left five family members dead Tuesday, including the gunman, authorities said.

from Biotech News

1 dead, 5 injured after UK power plant collapse

1 dead, 5 injured after UK power plant collapse
Vast coal seams dozens of feet thick that lie beneath the rolling hills of the Northern Plains once appeared almost limitless, fueling boasts that domestic reserves were sufficient to power the U.S. for centuries. Vast coal seams dozens of feet thick that lie beneath the rolling hills of the Northern Plains once appeared almost limitless, fueling boasts that domestic reserves were sufficient to power the U.S. for centuries.

from Biotech News

CDC probes possible sexually transmitted Zika cases

CDC probes possible sexually transmitted Zika cases
The Centers for Disease Control and Prevention says it is investigating 14 new reports of possible sexual transmission of the Zika virus. "These new reports suggest sexual transmission may be a more likely means of transmission for Zika virus than previously considered," the CDC said in a written statement.

from Biotech News

Rekombinase Brec1 richtungsweisend für zukünftige HIV-Therapie

Rekombinase Brec1 richtungsweisend für zukünftige HIV-Therapie
Forschern des Heinrich-Pette-Instituts (HPI) und der Medizinischen Fakultät der TU Dresden ist es gelungen, eine Designer-Rekombinase (Brec1) zu entwickeln, die das Provirus der meisten HIV-1-Primärisolate hochspezifisch aus dem Erbgut der Wirtszelle herausschneidet. Mit 37 Millionen HIV-positiven ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Johnson & Johnson must pay $72 million for cancer death linked to...

Johnson & Johnson must pay $72 million for cancer death linked to...
Johnson & Johnson was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company's talc-based Baby Powder and Shower to Shower for several decades. In a verdict announced late Monday night, jurors in the circuit court of St. Louis awarded the family of Jacqueline Fox $10 million of actual damages and $62 million of punitive damages, according to the family's lawyers and court records.

from Biotech News

New theorem helps reveal tuberculosis' secret

New theorem helps reveal tuberculosis' secret
A new methodology developed by researchers at Rice and Rutgers universities could help scientists understand how and why a biochemical network doesn't always perform as expected. To test the approach, they analyzed the stress response of bacteria that cause tuberculosis and predicted novel interactions.

from Biotech News

GSK underlines commitment to manufacturing in Scotland in 'near and distant future'

GSK underlines commitment to manufacturing in Scotland in 'near and distant future'
PHARMACEUTICALS giant GlaxoSmithKline is creating 55 jobs through a A 70 million extension of its antibiotics plant at Irvine in North Ayrshire. GSK employs 399 people at the Irvine plant.

from Biotech News

The Latest: Man says he called cops on driver before attacks

The Latest: Man says he called cops on driver before attacks
A gunman who seemed to choose his victims at random o... . Members of the community pray before the start of the Kalamazoo Community Prayer Service at Centerpoint Church on in Kalamazoo, Mich., Sunday, Feb 21, 2016.

from Biotech News

Amgen: A Biotech Buy And Hold Story

Amgen: A Biotech Buy And Hold Story
After a brutal bear market in biotech, the sector has turned up recently. The best way to take advantage of this possible bottoming is through large-cap growth plays.

from Biotech News

Al Mann Steps Down: What Does It Mean?

Al Mann Steps Down: What Does It Mean?
We have followed the Mannkind story since the company was dropped by Sanofi and has fallen into somewhat of a downward spiral since then. The company's burgeoning debt load is raising questions about the company's ability to continue and whether or not common equity holders will ultimately find any value in coming quarters.

from Biotech News

AbbVie auf Platz 2 der Top Arbeitgeber in Deutschland 2016

Изображение
AbbVie auf Platz 2 der Top Arbeitgeber in Deutschland 2016

Das forschende BioPharma-Unternehmen AbbVie Deutschland wird erneut für seine vorbildliche Mitarbeiterorientierung zertifiziert und ist unter den zwei "Top Arbeitgebern" in Deutschland 2016. Die jährliche Auszeichnung des Top Employers Institute zertifiziert Arbeitgeber, die exzellente Bedingungen f...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Auf Mutationen ausgerichtete T-Zellen gehen gegen Tumoren vor

Изображение
Auf Mutationen ausgerichtete T-Zellen gehen gegen Tumoren vor

Eine vielversprechende Strategie für zukünftige Krebstherapien: Immunzellen so zu modifizieren, dass sie Tumoren erkennen und abtöten. Anders als unspezifische Formen der T-Zell-Therapie verspricht die Ausrichtung auf Mutationen von Krebszellen, weniger Nebenwirkungen zu verursachen. In vorklinische...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Upcoming Reslizumab PDUFA- Approval Odds, And What It Means For Teva

Upcoming Reslizumab PDUFA- Approval Odds, And What It Means For Teva
Come March and investors in Teva would keenly await the USFDA decision on its novel asthma biologic drug candidate reslizumab. Reslizumab PDUFA action date is in March 2016.

from Biotech News

German nationalist leader rejects criticism of rhetoric

German nationalist leader rejects criticism of rhetoric
The fire damaged a former hotel that was being converted into a refugee home and two people were detained after hindering fi... Authorities trying to piece together an hours-long weekend rampage that left six people dead in western Michigan said they are looking into a report that the suspect picked up at least one fare for a ride-hailing... Authorities trying to piece together an hours-long weekend rampage that left six people dead in western Michigan said they are looking into a report that the suspect picked up at least one fare for a ride-hailing service... Lumber Liquidators' stock is plunging in premarket trading Monday as the Centers for Disease Control and Prevention now says people exposed to certain types of the company's laminate flooring were three... Lumber Liquidators' stock is plunging in premarket trading Monday as the Centers for Disease Control and Prevention now says ... (more)

from Biotech News

Researchers find link between death of tumor-support cells and cancer metastasis

Researchers find link between death of tumor-support cells and cancer metastasis
Researchers have discovered that eliminating cells thought to aid tumor growth did not slow or halt the growth of cancer tumors. In fact, when the cancer-associated fibroblasts , were eliminated after 10 days, the risk of metastasis of the primary tumor to the lungs and bones of mice increased dramatically.

from Biotech News

Ariad Pharmaceuticals, Inc. (ARIA) Scheduled to Post Quarterly Earnings on Tuesday

Ariad Pharmaceuticals, Inc. (ARIA) Scheduled to Post Quarterly Earnings on Tuesday
Ariad Pharmaceuticals, Inc. will be releasing its Q415 earnings data on Tuesday, February 23rd. Analysts expect Ariad Pharmaceuticals to post earnings of per share and revenue of $44.79 million for the quarter.

from Biotech News

Celgene Co. (CELG) Shares Bought by Wendell David Associates

Celgene Co. (CELG) Shares Bought by Wendell David Associates
Wendell David Associates increased its stake in Celgene Co. by 1.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission .

from Biotech News

A Look Back at 2 Successful Biotech Buyouts

A Look Back at 2 Successful Biotech Buyouts
The biotech pharmaceutical business is all about clinical trials, FDA approvals and the potential market its addresses. Most of the biotech companies experienced rising stock market prices despite the fact that it had consistently generated negative earnings over time.

from Biotech News

CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research

CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research
's stock had its "buy" rating reissued by Zacks Investment Research in a research note issued on Sunday, MarketBeat Ratings reports. They currently have a $20.00 price target on the stock.

from Biotech News

Athersys, Inc. (ATHX) Rating Reiterated by Maxim Group

Athersys, Inc. (ATHX) Rating Reiterated by Maxim Group
's stock had its "buy" rating reissued by equities researchers at Maxim Group in a report released on Sunday, AnalystRatings.Net reports. They currently have a $5.00 price target on the biopharmaceutical company's stock.

from Biotech News

Pfizer's Stock Price Is Scheduled To Pop

Pfizer's Stock Price Is Scheduled To Pop
On the 3rd of February of 2015, the Food and Drug Administration granted the "accelerated approval to Ibrance to treat advanced breast cancer." The FDA decided to grant Ibrance breakthrough therapy designation, "because the sponsor demonstrated through preliminary clinical evidence that the drug may offer a substantial improvement over available therapies."

from Biotech News

R. M. Davis Decreases Stake in Merck & Co., Inc.

R. M. Davis Decreases Stake in Merck & Co., Inc.
R. M. Davis lowered its stake in Merck & Co., Inc. by 7.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,288 shares of the company's stock after selling 1,852 shares during the period.

from Biotech News

First Financial Acquires 2,600 Shares of Pfizer Inc.

First Financial Acquires 2,600 Shares of Pfizer Inc.
First Financial raised its stake in Pfizer Inc. by 3.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 78,871 shares of the biopharmaceutical company's stock after buying an additional 2,600 shares during the period.

from Biotech News

Manning & Napier Advisors Has $6,628,000 Position in Mead Johnson Nutrition CO

Manning & Napier Advisors Has $6,628,000 Position in Mead Johnson Nutrition CO
Manning & Napier Advisors reduced its position in shares of Mead Johnson Nutrition CO by 4.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 83,960 shares of the company's stock after selling 3,570 shares during the period.

from Biotech News

What to do if you have the flu

What to do if you have the flu
Flu activity is increasing in the United States, according to new data from the Centers for Disease Control and Prevention, with widespread activity reported in 12 states -- Arizona, California, Connecticut, Iowa, Kentucky, Maryland, Massachusetts, New Mexico, New York, Pennsylvania, Texas and Vermont -- and Puerto Rico. Thirteen children have died as a result of the flu so far this flu season, the CDC reported on Friday.

from Biotech News

Gibraltar Capital Management Sells 355 Shares of Amgen, Inc.

Gibraltar Capital Management Sells 355 Shares of Amgen, Inc.
Gibraltar Capital Management lowered its stake in shares of Amgen, Inc. by 3.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 8,760 shares of the medical research company's stock after selling 355 shares during the period.

from Biotech News

IBM Grows Healthcare Cloud With $2.6bn Truven Buy

IBM Grows Healthcare Cloud With $2.6bn Truven Buy
Tech companies' desire to muscle in on medtech's turf shows no sign of abating. And IBM's latest purchase, of Truven Health Analytics for $2.6bn, illustrates another trend - the move towards payment for outcomes, with data becoming increasingly important in measuring cost-effectiveness.

from Biotech News

FDA clears expanded use of Pfizer's breast cancer med IBRANCE

FDA clears expanded use of Pfizer's breast cancer med IBRANCE
The FDA approves Pfizer's supplement New Drug Application for IBRANCE . It is now cleared for the treatment of hormone receptor-positive , human epidermal growth factor receptor 2-negative advanced/metastatic breast cancer in combination with fulvestrant [AstraZeneca's FASLODEX ] in women with disease progression following endocrine therapy.

from Biotech News

More people sick from salmonella linked to Garden of Life RAW Meal products

More people sick from salmonella linked to Garden of Life RAW Meal products
Health officials have identified seven more cases of salmonella illness linked to Garden of Life RAW Meal Organic Shake & Meal Products, the Centers for Disease Control and Prevention said Friday . Eighteen people across 15 states have become ill.

from Biotech News

Magee Thomson Investment Partners LLC Has $8,800,000 Stake in Alexion Pharmaceuticals, Inc.

Magee Thomson Investment Partners LLC Has $8,800,000 Stake in Alexion Pharmaceuticals, Inc.
Magee Thomson Investment Partners LLC boosted its position in Alexion Pharmaceuticals, Inc. by 1.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,130 shares of the biopharmaceutical company's stock after buying an additional 540 shares during the period.

from Biotech News

MannKind Founder Steps Down- Signals Are Not Good

MannKind Founder Steps Down- Signals Are Not Good
MannKind investors received news today that the founder, Executive Chairman, and Board of Directors member, Al Mann, has resigned as a company executive and as a board member. MannKind also announced that Kent Kresa will be promoted to Chairman of the Board of Directors.

from Biotech News

Benzodiazepine overdose death rate 'has increased four-fold'

Benzodiazepine overdose death rate 'has increased four-fold'
Benzodiazepines are a class of sedatives that includes Xanax, Valium and Klonopin. Although the Centers for Disease Control and Prevention have focused on opioids in the wake of the worsening drug epidemic in the US, results from a new study place benzodiazepines center stage in this epidemic.

from Biotech News

Get some sleep! One in three Americans not getting enough

Get some sleep! One in three Americans not getting enough
More than one out of three American adults do not get enough sleep, according to a study released Thursday from the U.S. Centers for Disease Control and Prevention. "That's a big problem" says, Dr. Nancy Collop, director of the Emory Sleep Center at Emory University School of Medicine in Atlanta, who is familiar with the study.

from Biotech News

Amgen Is The Cheapest Biotech - Cramer's Lightning Round

Amgen Is The Cheapest Biotech - Cramer's Lightning Round
Amgen : It's one of the cheapest biotech stocks. These have been hated due to the political situation but Cramer likes it.

from Biotech News

Why statin users should still get the flu shot, even if cholesterol drugs make it less effective

Why statin users should still get the flu shot, even if cholesterol drugs make it less effective
Every year in the United States, about 226,000 people are hospitalized because of the flu, and 23,000 die. And about 80-90 percent of flu-related deaths occur in people over 65 years old.

from Biotech News

Gymnastics Coach Accused of Statutory Rape in La Jolla Appears in Court

Gymnastics Coach Accused of Statutory Rape in La Jolla Appears in Court
A Santee gymnastics coach accused of having sex with a 15-year-old girl at La Jolla Shores pleaded not guilty Thursday to 12 charges, including statutory rape. Patrick Wehrung, 25, had posted $50,000 bail, but the bond was raised to $80,000 and he was taken back into custody.

from Biotech News

Six faculty elected fellows of AIMBE

Six faculty elected fellows of AIMBE
Six School of Medicine faculty members have been elected to the American Institute for Medical and Biological Engineering College of Fellows. Fellows are elected by their peers for their professional and public service accomplishments, research contributions and ability to serve as assets to the organization.

from Biotech News

Auf dem jobvector career day in Frankfurt Karrierechancen entdecken

Auf dem jobvector career day in Frankfurt Karrierechancen entdecken
Am 10. März 2016 ist es wieder soweit, das wichtigste Karriere-Event für Ingenieure und Naturwissenschaftler findet in Frankfurt statt – ein echtes Highlight für High-Tech Jobs. Dieses Jahr lockt jobvector Top-Arbeitgeber und Bewerber in den altehrwürdigen Frankfurter Palmengarten. Der Online-Stelle...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Hat Bayer einen neuen Konzernchef gefunden?

Hat Bayer einen neuen Konzernchef gefunden?
(dpa-AFX) Der Chemie- und Pharmakonzern Bayer hat laut einem Pressebericht einen neuen Konzernchef gefunden. Der frühere Finanz- und heutige Strategie-Chef Werner Baumann (53) werde Anfang 2017 die Nachfolge von Marijn Dekkers übernehmen, schrieb das "Manager Magazin" am Donnerstag unter Berufung au...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
The Company's results include the following: ... )--Keysight Technologies, Inc. today reported GAAP revenue of $721 million and non-GAAP revenue of $726 million for the first fiscal quarter ended Jan... )--Capella Education Company , a leading provider of online education, primarily through its wholly owned subsidiary Capella University, announced today tha... )--Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today provided an update on its fourth quarter and full year 2015 results and r... )--Universal Electronics Inc. , reported financial results for the three and twelve months ended December 31, 2015.

from Biotech News

Pharmaceutical executive Michael Jaharis dies at age 87

Pharmaceutical executive Michael Jaharis dies at age 87
Jaharis' death Wednesday at his home in New York was announced by Peggy Nicholson, the executive director of the Jaharis Family Foundation. She did not specify a cause.

from Biotech News

Biotech Stocks: Riding Out the Funding Storm

Biotech Stocks: Riding Out the Funding Storm
Biotechnology investors of all sorts would like the bear market to go away. But smaller biotech companies are rooting just a little harder for blue skies to return.

from Biotech News

Viagra - Melanoma Lawsuits Mounting

Viagra - Melanoma Lawsuits Mounting
The Judicial Panel on Multidistrict Litigation will hold a hearing to consider a request to establish coordinated national litigation against the manufacturers of Viagra. The Judicial Panel is a group of federal judges who meet every other month to consider requests for the establishment of multidistrict litigation for cases involving multiple plaintiffs, which usually include drug and medical device product liability claims, class actions, securities lawsuits, and claims involving mass accidents or natural disasters.

from Biotech News

UPDATE 1-UK cost agency queries value of $700,000-a-year Alexion drug

UPDATE 1-UK cost agency queries value of $700,000-a-year Alexion drug
An enzyme treatment from Alexion Pharmaceuticals costing 491,992 pounds a year may be worth using in babies with a rare disorder but does not represent good value for all patients, Britain's healthcare cost watchdog said. Kanuma is designed for treating lysosomal acid lipase deficiency, a rare inherited genetic disease in which fats build up in cells.

from Biotech News

Roche investiert 570 Millionen Euro am Standort Deutschland

Изображение
Roche investiert 570 Millionen Euro am Standort Deutschland

Das Pharmageschäft von Roche wächst 2015 um 7,1 Prozent auf 1.726 Millionen Euro und damit stärker als der Markt (+5 %). "Unser Wachstum beruht auf der gestiegenen Nachfrage insbesondere nach unseren neuen Medikamenten in der Onkologie und gegen Atemwegserkrankungen sowie gegen Rheumatoide Arthritis...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Kollegen sind in Bayern auch Freunde − und verdienen gut!

Изображение
Kollegen sind in Bayern auch Freunde − und verdienen gut!

Mit einem durchschnittlichen Brutto-Jahresgehalt von 65.428 Euro (ohne Zusatzleistungen) belegt Baden-Württemberg die Poleposition im bundesweiten Gehaltsvergleich. Zu diesem Ergebnis kommt der erste große B2B-Gehaltsreport von Vogel Business Media in Kooperation mit dem Online-Stellenmarkt Jobware....

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Nominations Open For Annual George Washington Carver Award And Rosalind Franklin Award

Nominations Open For Annual George Washington Carver Award And Rosalind Franklin Award
On February 1, 2016, the Biotechnology Innovation Organization announced that nominations for the ninth annual George Washington Carver Award were being accepted . The award recognizes an individual who has contributed to building the biobased economy by creating sustainable, environmentally friendly products through industrial biotechnology.

from Biotech News

Dr. Reddy Is Transitioning From A Pure Generic Player To An Innovator

Dr. Reddy Is Transitioning From A Pure Generic Player To An Innovator
Currently it is just the warning letter that is at the top of everybody's mind when it comes to investing in Dr. Reddy. By 2022, Proprietary product business alone should contribute about INR 70 per share to the EPS.

from Biotech News

Celgene Maintains Earnings Promises, But Jolts The Balance Sheet And Returns

Celgene Maintains Earnings Promises, But Jolts The Balance Sheet And Returns
However, the balance sheet was levered up, and Return on Capital Invested took a hit in order to maintain aggressive growth aspirations. Recently, bio-pharma heavyweight Celgene Corp. reported another set of solid 4Q and full-year results.

from Biotech News

UPDATE 1-U.S. FDA likely underestimated fetal deaths from Essure -analyst

UPDATE 1-U.S. FDA likely underestimated fetal deaths from Essure -analyst
The U.S. Food and Drug Administration may have greatly underestimated the number of fetal deaths among women who became pregnant after using Bayer AG's Essure contraceptive device, according to a private analyst who combed through the agency's public database. The FDA has cited five fetal deaths in women who became pregnant after using Essure, two metal coils inserted into the fallopian tubes.

from Biotech News

Roche: FDA gewährt MS-Prüfmedikament Ocrelizumab den Status Therapiedurchbruch

Roche: FDA gewährt MS-Prüfmedikament Ocrelizumab den Status Therapiedurchbruch
(dpa-AFX) Der Pharmakonzern Roche hat von der US-Gesundheitsbehörde FDA für sein Prüfmedikament Ocrelizumab gegen primär progrediente multiple Sklerose (PPMS) den Status Therapiedurchbruch erhalten. Damit ist Ocrelizumab das erste Mittel gegen multiple Sklerose (MS), das diesen Status erhält, heißt ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Your Body: Paying for Therapy Out of Pocket

Your Body: Paying for Therapy Out of Pocket
How much are you willing to pay for therapies not covered by insurance? According to a recent study from the Centers for Disease Control and Prevention, a lot. Acupuncture, chiropractic and massage therapy have all grown in popularity between 2002 and 2012.

from Biotech News

Arena- Belviq Sales Continue To Under-Perform And Underwhelm

Arena- Belviq Sales Continue To Under-Perform And Underwhelm
Arena saw U.S. sales of Belviq continue to under-perform levels needed to impress the street this past week. Sales are 12% off of the pace established in Q4, and are down a stunning 22% from the levels we were seeing just a year ago.

from Biotech News

Fatal Crash Suit Claims Doc Knew Woman Shouldn't Drive

Fatal Crash Suit Claims Doc Knew Woman Shouldn't Drive
NBC 7's Dave Summers reports on the lawsuit filed against Dr. Gaston Molina and Scripps Health in the fatal crash involving two women in La Jolla in October 2014. A well-known San Diego hospital and physician face a wrongful death lawsuit filed Tuesday that claims they did not stop a patient from driving before she killed a La Jolla woman in October of 2014.

from Biotech News

Sea lion found starving in San Diego restaurant on the mend

Sea lion found starving in San Diego restaurant on the mend
In a photo provided by SeaWorld, an 8-month-old female sea lion pup is shown where it was found sleeping in a booth of the Marine Room, an upscale restaurant in the La Jolla neighborhood of San Diego, Thursday, Feb. 4, 2016. Experts were called from nearby SeaWorld, who said the pup was severely underweight and dehydrated.

from Biotech News

Pharma-Unternehmen auf Shoppingtour

Изображение
Pharma-Unternehmen auf Shoppingtour

Ausnahmejahr für die Pharma-Branche: Mega-Deals haben dazu beigetragen, dass die Unternehmen 2015 ihren eigenen M&A-Rekord aus dem Vorjahr noch einmal deutlich übertroffen haben. Mit knapp 328 Milliarden US-Dollar gab die Branche so viel wie noch nie für Fusionen und Übernahmen aus. Das entspricht e...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Support grows for genetically modified mosquitoes in Zika fight

Support grows for genetically modified mosquitoes in Zika fight
It may be necessary to use controversial methods like genetically modified mosquitoes to wipe out the insects that are now spreading Zika acrossthe Americas, the World Health Organization said Tuesday. Support grows for genetically modified mosquitoes in Zika fight It may be necessary to use controversial methods like genetically modified mosquitoes to wipe out the insects that are now spreading Zika acrossthe Americas, the World Health Organization said Tuesday.

from Biotech News

Aust shares close lower

Aust shares close lower
The Australian share market has closed lower, with heavy hitters BHP Billiton, Woodside Petroleum and vaccine giant CSL weighing on sentiment.

from Biotech News

Tarnkappen-Effekt bei Nanocarriern als Medikamenten-Transporter künftig noch besser nutzbar

Изображение
Tarnkappen-Effekt bei Nanocarriern als Medikamenten-Transporter künftig noch besser nutzbar

Wissenschaftler der Universitätsmedizin Mainz und des Max-Planck-Instituts für Polymerforschung (MPI-P) entschlüsseln Stealth-Effekt von Nanocarriern gegen Fresszellen des Immunsystems. Mithilfe von „Medikamenten-Transportern“, sogenannten Nanocarriern, gelangen Wirkstoffe an erkrankte Stellen im K...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Large 'pay for delay' fine imposed by CMA

Large 'pay for delay' fine imposed by CMA
On the 12th of February 2016, the UK Competition and Markets Authority fined GlaxoSmithKline and the successor companies to Alpharma Limited around 45m in total for breaches of Chapter I of the Competition Act 1998, the prohibition against anti-competitive agreements. The case shows the continued danger in pharmaceuticals reaching settlement agreements in IP disputes with generic drug providers.

from Biotech News

Dengue fever: what you need to know

Dengue fever: what you need to know
Like Zika virus, dengue fever is spread to people through mosquito bites. The Centers for Disease Control and Prevention says dengue fever is a leading cause of illness and death in the tropics and subtropics, with as many as 400 million people infected yearly.

from Biotech News

How the mainstream media act as shameless shills for the biotech industry

How the mainstream media act as shameless shills for the biotech industry
Alternative health and news sites like ours have, in fact, proliferated in large part because we provide the honest, bare-bones truth about GMOs. But alas, most mainstream media does not.

from Biotech News

Mylan - Positive Investment Alert

Mylan - Positive Investment Alert
Mylan stock price has corrected about 20% soon after announcing that it intends to buy Europe based specialty pharma company - Meda. The price offered is a 90% premium to Meda's last traded price.

from Biotech News

DEALTALK-Market turmoil drives small biotechs to big pharma

DEALTALK-Market turmoil drives small biotechs to big pharma
Feb 16 Numerous small biotechnology companies have been all but shut out of the capital markets, leaving many with no choice but to consider a sale to larger peers. The Nasdaq Biotech Index is down nearly 30 percent since September, when Democratic presidential candidate Hillary Clinton criticized drug companies' "price gouging" on Twitter and sparked concerns about a government crackdown on rising drug costs.

from Biotech News

Retirement Strategy: Is Now The Time To Consider A More Defensive Portfolio?

Retirement Strategy: Is Now The Time To Consider A More Defensive Portfolio?
It might be time to consider a portfolio that has less exposure to all global issues as well as interest rate concerns. I have been a perma-bull for over 7 years now, and the Team Alpha Retirement Portfolio reflects the success of my belief.

from Biotech News

Ligand Pharmaceuticals Inc. to Post Q1 2016 Earnings of $0.46 Per...

Ligand Pharmaceuticals Inc. to Post Q1 2016 Earnings of $0.46 Per...
Ligand Pharmaceuticals Inc. - Equities research analysts at Craig Hallum upped their Q1 2016 earnings estimates for shares of Ligand Pharmaceuticals in a research report issued to clients and investors on Thursday, according to Zacks Investment Research . Craig Hallum analyst M. Tiampo now anticipates that the brokerage will post earnings of $0.46 per share for the quarter, up from their prior forecast of $0.44.

from Biotech News

Test von Zika-Impfstoff wird schon 2016 starten

Test von Zika-Impfstoff wird schon 2016 starten
(dpa) Wissenschaftler werden nach Einschätzung eines US-Experten noch in diesem Jahr einen Impfstoff gegen das Zika-Virus testen. «Wir werden zum Ende des Sommers einen Impfstoff-Kandidaten haben und der wird noch in diesem Jahr bereit für erste Tests sein», sagte der Direktor des Nationalen Institu...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Strafe für GlaxoSmithKline

Strafe für GlaxoSmithKline
(dpa-AFX) Der britische Phamakonzern GlaxoSmithKline soll wegen unerlaubter Zahlungen an Generika-Hersteller eine Millionenstrafe zahlen. Die Geldbuße in Zusammenhang mit dem Antidepressivum Paroxetin beläuft sich auf 37,6 Millionen Pfund (48,1 Mio Euro), wie die britische Wettbewerbsbehörde CMA am ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

T-Zelltherapie bringt Fortschritte im Kampf gegen Krebs und Infektionskrankheiten

T-Zelltherapie bringt Fortschritte im Kampf gegen Krebs und Infektionskrankheiten
In den letzten Jahren haben die Bemühungen, Immuntherapien in den breiten klinischen Einsatz gegen Krebs und Infektionskrankheiten zu bringen, große Fortschritte gemacht. So brachten beispielsweise klinische Studien mit der sogenannten adoptiven T-Zelltherapie sehr vielversprechende Ergebnisse. Drei...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Gilead Has Bottomed - The Question Is How Much Upside Ahead?

Gilead Has Bottomed - The Question Is How Much Upside Ahead?
It has been a frightful six months for biotech investors as the main biotech indices have plunged some 40% from their peaks in July. However, it does appear the some of the big biotech names are in a bottoming phase which is needed before the sector can rally.

from Biotech News

BTR Capital Management Has $520,000 Position in Bristol-Myers Squibb Co

BTR Capital Management Has $520,000 Position in Bristol-Myers Squibb Co
BTR Capital Management raised its position in shares of Bristol-Myers Squibb Co by 8.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,565 shares of the biopharmaceutical company's stock after buying an additional 600 shares during the period.

from Biotech News

Mead Johnson Nutrition CO (MJN) Position Increased by First Personal Financial Services

Mead Johnson Nutrition CO (MJN) Position Increased by First Personal Financial Services
First Personal Financial Services raised its stake in shares of Mead Johnson Nutrition CO by 7.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,653 shares of the company's stock after buying an additional 1,250 shares during the period.

from Biotech News

Schenectady County, N.Y. resident being tested for possible Zika virus

Schenectady County, N.Y. resident being tested for possible Zika virus
This 2006 file photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. The The Centers for Disease Control and Prevention on Tuesday, Jan. 19, 2016, announced new guidance for doctors whose pregnant patients may have traveled to regions with a tropical illness linked to birth defects.

from Biotech News

AIDS-Impfstoffproduktion in Algen

Изображение
AIDS-Impfstoffproduktion in Algen

Pflanzen und Mikroorganismen werden vielfältig zur Medikamentenproduktion genutzt. Die Produktion solcher Biopharmazeutika in Pflanzen nennt man auch „Molecular Pharming“. Sie ist ein stetig wachsendes Feld der Pflanzenbiotechnologie. Hauptorganismen sind vor allem Hefe und Nutzpflanzen, wie Mais un...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Ratiopharm-Mutter Teva mit Gewinneinbruch

Ratiopharm-Mutter Teva mit Gewinneinbruch
(dpa-AFX) Der Ratiopharm-Mutterkonzern Teva hat sich 2015 mit einem teuren Rechtsstreit und einer geplatzten Übernahme einen herben Gewinnrückgang eingebrockt. Unter dem Strich verdiente der israelische Pharmahersteller mit 1,6 Milliarden US-Dollar (1,4 Mrd Euro) nur noch gut halb so viel wie im Vor...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Mylan versucht es nach Perrigo-Pleite mit Brechstange

Mylan versucht es nach Perrigo-Pleite mit Brechstange
(dpa-AFX)  Der US-Pharmakonzern Mylan packt nach dem gescheiterten Übernahmeversuch in Irland bei seinem nächsten Zielobjekt die Brechstange aus. Dabei handelt es sich um den schwedischen Konkurrenten Meda, wie die Amerikaner am Mittwoch mitteilten. Mylan bietet 165 Schwedische Kronen je Aktie. Im V...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Verkaufserlös für Boehringer-Tochter Roxane gesunken